Occludin immunostaining and prognosis colorectal adenocarcinomas, clear cell and papillary carcinomas of the kidney, serous ovarian cancers, and pancreatic adenocarcinomas. See materials and methods section for definition of the immunostaining levels. This evidence concerns the gene OCLN and ovarian serous adenocarcinoma.